• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

MUMBAI: Merck Ltd has approved the sale of its life science and analytics business (excluding bulk drugs) to Merck Specialities Pvt Ltd for a consideration of Rs 99.2 crore.

Merck Specialities is a 100 per cent subsidiary of affiliates of Merck KGaA, Germany. The decision taken at the Mumbai-based company's board meeting here on Friday is subject to shareholders' approval, the company told the BSE.

More Stories on : Announcements

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Merck to sell life science biz

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line